Disturbed trophoblast transition links early fetal to maternal syndrome progression in pre-eclampsia
Ontology highlight
ABSTRACT: Pre-eclampsia (PE) is a syndrome that affects multiple organ systems and is the most severe hypertensive disorder in pregnancy. It frequently leads to preterm delivery, maternal and fetal morbidity and mortality, and life-long complications. We currently lack efficient screening tools and early therapies to address PE. To study the initial stages of early onset PE and identify candidate markers and pathways, we performed spatio-temporal multi-omics profiling of human PE placentae and healthy controls and validated targets in early gestation in a longitudinal clinical cohort. We used a single nuclei RNA-seq approach combined with spatial proteo- and transcriptomics and mechanistic in vitro signaling analyses. We discovered a key disruption in trophoblast transition, which is driven by the increase of transcriptional coactivator p300 that ultimately ends with a senescence-associated secretory phenotype (SASP) of trophoblasts. We found a significant increase in the senescence marker Activin-A in preeclamptic maternal serum in early gestation, before the development of clinical symptoms, indicating a translation of the fetal syndrome to the maternal side. Our work identifies potential new biomarkers for the early diagnosis of the disease and possible targets for interventions, which would be crucial steps toward protecting the mother and child from gestational mortality and morbidity and an increased risk of cardiovascular disease later in life. This study includes early placentae samples from the fetal part (villi; n=10), maternal part (Decidua; n=3), late placentae samples from healthy pregnancies, villi (n=6), decidua (n=4), and late placentae samples from early onset preeclamptic pregnancies, villi (n=5) and decidua (n=5).
PROVIDER: EGAS00001005681 | EGA |
REPOSITORIES: EGA
ACCESS DATA